ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Huakang Biomedical Holdings Co's annualizedNet Income for the quarter that ended in Jun. 2024 was HK$0.00 Mil.
Huakang Biomedical Holdings Co's average Total Assets over the quarter that ended in Jun. 2024 was HK$71.67 Mil. Therefore, Huakang Biomedical Holdings Co's annualized ROA % for the quarter that ended in Jun. 2024 was 0.00%.
The historical rank and industry rank for Huakang Biomedical Holdings Co's ROA % or its related term are showing as below:
HKSE:08622'
s ROA % Range Over the Past 10 Years
Min: -15.86 Med: -4.4 Max: 28.86
Current: -8.89
During the past 9 years, Huakang Biomedical Holdings Co's highest ROA % was 28.86%. The lowest was -15.86%. And the median was -4.40%.
HKSE:08622's ROA % is ranked worse than 71.91% of 1068
companies
in the Drug Manufacturers industry
Industry Median: 1.585
vs HKSE:08622: -8.89
Huakang Biomedical Holdings Co ROA % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Huakang Biomedical Holdings Co's ROA %
For the Drug Manufacturers - Specialty & Generic subindustry, Huakang Biomedical Holdings Co's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Huakang Biomedical Holdings Co's ROA % Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Huakang Biomedical Holdings Co's ROA % distribution charts can be found below:
* The bar in red indicates where Huakang Biomedical Holdings Co's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Jun. 2024) net income data.
ROA % is displayed in the 30-year financial page.
Huakang Biomedical Holdings Co (HKSE:08622) ROA % Explanation
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is four times the quarterly (Jun. 2024) net income data. The Revenue data used here is four times the quarterly (Jun. 2024) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
Huakang Biomedical Holdings Co ROA % Related Terms
Thank you for viewing the detailed overview of Huakang Biomedical Holdings Co's ROA % provided by GuruFocus.com. Please click on the following links to see related term pages.
Huakang Biomedical Holdings Co Business Description
Huakang Biomedical Holdings Co Ltd is engaged in the research, development, manufacture, marketing, and sale of in-vitro diagnostic reagents and auxiliary reproductive supplies and equipment in China. Its products include Male fertility IVD reagents; Parasite antibody detection reagents; EBV antibody detection reagents; and Auxiliary reproductive supplies and equipment. The group has also diversified its business to vitamins and supplements products for the markets in the PRC, Hong Kong, and overseas.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:08622 has been successfully added to your 